Blog
RSS FeedPosted by Michael Wonder on 10 Jun 2019
The $2.1 million question: what are the medical, ethical implications of the world's priciest drug?
10 June 2019 - With last month’s FDA approval, Zolgensma became the world’s most expensive medication. ...
Posted by Michael Wonder on 10 Apr 2019
ALP cancer plan ‘divisive, inequitable’
11 April 2019 - Labor’s decision to prioritise fee relief for cancer patients is a departure from its previous policies ...
Posted by Michael Wonder on 13 Dec 2018
Frustrated at cancer treatment inequity
13 December 2018 - As appointed ambassador for the Lung Foundation NZ, I feel very frustrated the Government will not ...
Posted by Michael Wonder on 30 Jul 2018
Health system neglects vulnerable Australians: Grattan Institute report
30 July 2018 - Vulnerable Australians are being neglected by a primary health system that is poorly integrated, lacks direction ...
Posted by Michael Wonder on 28 Jul 2018
Tackling inequalities to improve wellbeing in New Zealand
28 July 2018 - In May, 2018, Jacinda Ardern's New Zealand Government announced their first budget and, in a world first, ...
Posted by Michael Wonder on 26 Apr 2018
Mission possible: moving the needle forward to advance health equity
26 April 2018 - Every April our country observes National Minority Health Month to spotlight what we’re doing to eliminate health ...
Posted by Michael Wonder on 16 Apr 2018
WA accuses Canberra of $1 billion health care rip-off
16 April 2018 - West Australians are missing out on $1 billion in federal health funding in a "Canberra rip-off", ...
Posted by Michael Wonder on 07 Dec 2017
PHARMAC commits to equity target by 2025
7 December 2017 - Achieving equity in medicines access is one of the bold goals PHARMAC has set itself to ...
Posted by Michael Wonder on 06 Jun 2017
America is a world leader in health inequality
5 June 2017 - The divide between health outcomes for the richest and poorest Americans is among the largest in ...
Posted by Michael Wonder on 07 May 2017
Redistribution and redesign in health care: an ebbing tide in England versus growing concerns in the United States
4 May 2017 - Like many countries, the health care industries of England and the United States consume large amounts ...
Posted by Michael Wonder on 14 Mar 2017
Trading health care for the poor for tax cuts for the rich
13 March 2017 - So much for President Trump’s pledge of “insurance for everybody.” ...
Posted by Michael Wonder on 11 Jul 2016
A comprehensive and fair solution to the price of medicines
5 July 2016 - After a long dry spell, the pharmaceutical research industry has brought to market a spate of ...
Posted by Michael Wonder on 09 Jul 2016
Why the WHO plans a fair pricing model for drugs
7 July 2016 - Over the next year, the World Health Organization wants to develop a fair pricing model for pharmaceuticals. ...
Posted by Michael Wonder on 05 Jul 2016
Accelerated drug approval and health inequality
5 July 2016 - This Viewpoint argues that the acceleration of the drug approval process could unequally distribute the costs and ...
Posted by Michael Wonder on 13 Jun 2016
Why cancer?
14 June 2016 - Throughout my career as a health economist, one issue has always been a mystery to me—why does ...